Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
Clinical trial NCT06461988 · RECRUITING
Trial details
- NCT number
- NCT06461988
- Sponsor
- Stanford University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-05
- Primary completion
- 2027-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.